673-09-6

Basic information

• Product Name: Benzenamine, 4-(4-pyridinylthio)-
• CAS NO: 673-09-6
• Molecular Formula: C11H10N2S
• Molecular Weight: 202.28
• Mol File: 673-09-6.mol
• Article Data: 10

Chemical Properties

• CAS DataBase Reference: Benzenamine, 4-(4-pyridinylthio)-(CAS DataBase Reference)
• NIST Chemistry Reference: Benzenamine, 4-(4-pyridinylthio)-(673-09-6)
• EPA Substance Registry System: Benzenamine, 4-(4-pyridinylthio)-(673-09-6)

Safety Data

• Hazardous Substances Data: 673-09-6(Hazardous Substances Data)

Upstream product

• 100-00-5 4-chlorobenzonitrile 
• 7379-35-3 4-chlorpyridine hydrochloride 
• 1193-02-8 4-aminotiophenol 
• 852448-31-8 (4-mercaptophenyl)carbamic acid tert-butyl ester 
• 636-98-6 p-nitrobenzene iodide 
• 100-01-6 4-nitro-aniline 
• 4556-23-4 pyridine-4-thiol 
• 746630-21-7 4-((4-nitrophenyl)thio)pyridine 

Downstream Products

• 52024-36-9 4-(4-isothiocyanato-phenylthio)-pyridine 
• 570415-41-7 N-(2-amino-6-ethyl-4-pyrimidinyl)-N-[4-(4-pyridinylsulfanyl)phenyl]amine 
• 569658-16-8 N₄-[4-(pyridin-4-ylsulfanyl)-phenyl]-6,7,8,9-tetrahydro-5H-cycloheptapyrimidine-2,4-diamine 
• 1020087-58-4 4-nitro-N-[4-(pyridin-4-ylthio)phenyl]benzamide 

Relevant articles and documents

ANTI-MUCUS DRUGS AND USES THEREFOR

Disclosed are methods of identifying, generating and synthesizing compounds that inhibit MAPK13 activity. In various embodiments, compounds, salts thereof and prodrugs thereof of the present teachings can be useful for the treatment of diseases and disord

QUINOLINE DERIVATIVES FOR MODULATING DNA METHYLATION

Quinoline derivatives, particularly 4-anilinoquinoline derivatives, are provided. Such quinoline derivatives can be used for modulation of DNA methylation, such as effective inhibition of methylation of cytosine at the C-5 position, for example via selective inhibition of DNA methyltransferase DNMT1. Methods for synthesizing numerous 4-anilinoquinoline derivatives and for modulating DNA methylation are provided. Also provided are methods for formulating and administering these compounds or compositions to treat conditions such as cancer and hematological disorders.

Rho-kinase inhibitors

Disclosed are compounds and derivatives thereof, their synthesis, and their use as Rho-kinase inhibitors. These compounds are useful for inhibiting tumor growth, treating erectile dysfunction, and treating other indications mediated by Rho-kinase, e.g., c